Literature DB >> 23036729

[Clinical practice guideline on the management of patients with dyspepsia. Update 2012].

Javier P Gisbert1, Xavier Calvet, Juan Ferrándiz, Juan Mascort, Pablo Alonso-Coello, Mercè Marzo.   

Abstract

The aim of the Clinical Practice Guideline (CPG) on the Management of Patients with Dyspepsia is to generate recommendations on the optimal approach to dyspepsia in the primary care and specialized outpatient setting. The main objective of this CPG is to help to optimize the diagnostic process, identifying patients with a low risk of a serious organic disease (mainly tumoral), who could be safely managed without the need for invasive diagnostic tests and/or referral to a specialist. The importance of this aim lies in the need to accurately diagnose patients with esophagogastric cancer and correctly treat peptic ulcer while, at the same time, reduce negative endoscopies in order to appropriately use the available healthcare resources. This CPG reviews the initial strategies that can be used in patients with uninvestigated dyspepsia and evaluates the possible decision to begin empirical therapy or to investigate the existence of a lesion that could explain the symptoms. This CPG also discusses functional dyspepsia, which encompasses all patients with dyspepsia with no demonstrable cause on endoscopy. Recommendations for the diagnosis and treatment of peptic ulcer and Helicobacter pylori infection are also made. To classify the scientific evidence and strengthen the recommendations, the GRADE (Grading of Recommendations Assessment, Development and Evaluation Working Group) system has been used (http://www.gradeworkinggroup.org/).
Copyright © 2012 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23036729      PMCID: PMC7025630          DOI: 10.1016/j.aprim.2012.05.003

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  228 in total

1.  Reliability of symptom assessment in dyspepsia.

Authors:  R C Heading; E Wager; P J Tooley
Journal:  Eur J Gastroenterol Hepatol       Date:  1997-08       Impact factor: 2.566

2.  Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study.

Authors:  Fermín Mearin; Marc Pérez-Oliveras; Antonia Perelló; Jaume Vinyet; Anabel Ibañez; Jordi Coderch; Mónica Perona
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

3.  Absence of dyspeptic symptoms as a test of Helicobacter pylori eradication.

Authors:  P S Phull; D Halliday; A B Price; M R Jacyna
Journal:  BMJ       Date:  1996-02-10

Review 4.  Functional dyspepsia: the role of visceral hypersensitivity in its pathogenesis.

Authors:  John Keohane; Eamonn M M Quigley
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

5.  Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia.

Authors:  J Christie; N A Shepherd; B W Codling; R M Valori
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

6.  Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients.

Authors:  J P Gisbert; J-L Gisbert; S Marcos; I Jimenez-Alonso; R Moreno-Otero; J M Pajares
Journal:  Aliment Pharmacol Ther       Date:  2007-11-12       Impact factor: 8.171

7.  Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: a cost-effectiveness analysis.

Authors:  R J Laheij; J L Severens; E H Van de Lisdonk; A L Verbeek; J B Jansen
Journal:  Aliment Pharmacol Ther       Date:  1998-12       Impact factor: 8.171

8.  Clinical and pathophysiological characteristics of acute-onset functional dyspepsia.

Authors:  Jan Tack; Ingrid Demedts; Geert Dehondt; Philip Caenepeel; Benjamin Fischler; Michele Zandecki; Jozef Janssens
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

9.  Empirical treatment followed by a test-and-treat strategy is more cost-effective in comparison with prompt endoscopy or radiography in patients with dyspeptic symptoms: a randomized trial in a primary care setting.

Authors:  R J F Laheij; J Th Hermsen; J B M J Jansen; A M Horrevorts; R J Rongen; L G M Van Rossum; E Witteman; R W de Koning
Journal:  Fam Pract       Date:  2004-06       Impact factor: 2.267

10.  Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection.

Authors:  Deng-Chyang Wu; Ping-I Hsu; Jeng-Yih Wu; Antone R Opekun; Chao-Hung Kuo; I-Chen Wu; Sophie S W Wang; Angela Chen; Wen-Chun Hung; David Y Graham
Journal:  Clin Gastroenterol Hepatol       Date:  2009-10-03       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.